By Editor , 20 September 2026
Dnotitia's Vector Chip Cuts CPU Load 92%, Boosts Search 5.77x

Santa Clara – September 20, 2026 -- Dnotitia Inc. has received back the first ASIC samples of its Vector Data Processing Unit (VDPU) from fabrication, with chip-level characterization now underway and silicon-based server evaluations scheduled for the fourth quarter of 2026. The company disclosed the milestone at AI Infra Summit 2026, held Sept. 15-17 at the Santa Clara Convention Center, where it showcased a server-scale VDPU architecture built for vector retrieval workloads in retrieval-augmented generation and agentic AI systems.

By Editor , 20 September 2026
InventHelp Unveils Hellcat-to-Coyote Supercharger Adapter for Licensing

Pittsburgh – September 20, 2026 -- InventHelp has submitted a new invention, the "Hellcat Supercharger to Coyote Adapters," designed to solve compatibility problems between supercharger systems and Coyote engines used in automotive performance builds. The concept, developed by an inventor from Wichita, Kan., is now available for licensing or sale to manufacturers and marketers.

By Editor , 20 September 2026
Wuffes Launches IgY-Powered Dental Powder, Enters $2.59B Pet Oral Care Market

Cheyenne, Wyo. – September 20, 2026 -- Wuffes, the dog supplement brand that has served more than 1.3 million dog parents, has launched a Dental Powder range built on SuperYolkTM IgY Technology, a proprietary ingredient the company says is the first of its kind in the US canine dental supplement market.

By Editor , 20 September 2026
QCi Unveils Integrated Quantum Encryption-Authentication Platform at ECOC

Hoboken, N.J. – September 20, 2026 -- Quantum Computing Inc. (Nasdaq: QUBT) will demonstrate, for the first time, a platform combining quantum key distribution (QKD) with hardware-based Quantum Identity Authentication (QIA) on a single system at ECOC Exhibition 2026, running September 21-23 at FYCMA in Málaga, Spain.

By Editor , 20 September 2026
Andelyn Begins Commercial Manufacturing of FDA-Approved Gene Therapy FAYUVI

Columbus, Ohio – September 20, 2026 -- Andelyn Biosciences has begun commercial manufacturing of FAYUVI (rebisufligene etisparvovec-hopf) at its Columbus facility, marking the first FDA-approved gene therapy produced using the company's AAV Curator Platform process. The therapy, developed by Ultragenyx Pharmaceutical Inc., recently received U.S. Food and Drug Administration approval for treating Sanfilippo syndrome type A, also known as mucopolysaccharidosis type IIIA (MPS IIIA).

By Editor , 20 September 2026
SOCO Launches ODORSORB-101 to Chemically Capture Industrial Odors

Qingdao – September 19, 2026 -- Qingdao SOCO New Material Co., Ltd. has launched ODORSORB-101, a plant-based liquid formulated to chemically capture nitrogen- and sulfur-based odor compounds at industrial and municipal sites rather than mask them.

By Editor , 20 September 2026
mAbxience, Sandoz Partner on Emicizumab Biosimilar for Hemophilia A

Madrid – September 19, 2026 -- mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed emicizumab biosimilar targeting hemophilia A, a treatment referencing Roche's Hemlibra with an estimated global reference market of USD 5.7 billion.